Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF STATING FOR THE TREATMENT OF METABOLIC SYNDROME
Document Type and Number:
WIPO Patent Application WO2005058310
Kind Code:
A3
Abstract:
The present invention relates to the use of a pharmaceutical composition consisting of a statin (especially fluvastatin or pitavastatin) or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier for the preparation of a medicament for the prevention or treatment of metabolic syndrome (or syndrome X).

Inventors:
BORTOLINI MICHELE (CH)
Application Number:
PCT/EP2004/014304
Publication Date:
August 25, 2005
Filing Date:
December 15, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NOVARTIS AG (CH)
NOVARTIS PHARMA GMBH (AT)
BORTOLINI MICHELE (CH)
International Classes:
A61K31/404; A61K31/47; (IPC1-7): A61K31/404; A61K31/47; A61P3/06
Domestic Patent References:
WO2003080070A22003-10-02
WO2001076573A22001-10-18
WO2004096276A12004-11-11
Other References:
HAFFNER S M ET AL: "Metabolic syndrome - A new risk factor of coronary heart disease?", DIABETES, OBESITY AND METABOLISM 2003 UNITED KINGDOM, vol. 5, no. 6, November 2003 (2003-11-01), pages 359 - 370, XP002330145, ISSN: 1462-8902
SOWERS J R: "Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome", AMERICAN JOURNAL OF CARDIOLOGY 20 FEB 2003 UNITED STATES, vol. 91, no. 4 SUPPL., 20 February 2003 (2003-02-20), pages 14B - 22B, XP002330146, ISSN: 0002-9149
GRUNDY S M: "Metabolic syndrome: What is it and how should i treat it?", ACC CURRENT JOURNAL REVIEW 2003 UNITED STATES, vol. 12, no. 3, June 2003 (2003-06-01), pages 37 - 40, XP002330147, ISSN: 1062-1458
Download PDF: